217 related articles for article (PubMed ID: 9704695)
1. Patients with stable chronic obstructive pulmonary disease can safely undergo intravenous dipyridamole thallium-201 imaging.
Shaffer J; Simbartl L; Render ML; Snow E; Chaney C; Nishiyama H; Rauf GC; Wexler LF
Am Heart J; 1998 Aug; 136(2):307-13. PubMed ID: 9704695
[TBL] [Abstract][Full Text] [Related]
2. Severe bronchospasm followed by respiratory arrest during thallium-dipyridamole imaging.
Lette J; Cerino M; Laverdiere M; Tremblay J; Prenovault J
Chest; 1989 Jun; 95(6):1345-7. PubMed ID: 2721274
[TBL] [Abstract][Full Text] [Related]
3. The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Intravenous Dipyridamole Thallium Imaging Study Group.
Ranhosky A; Kempthorne-Rawson J
Circulation; 1990 Apr; 81(4):1205-9. PubMed ID: 2107985
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacological stimulation with dipyridamole in thallium-201 myocardial perfusion scintigraphy: a study of the secondary effects].
Colarinha P; Salgado L; Sá EP; Matias F; Adão M; Correia JF; Vieira MR
Rev Port Cardiol; 1996 Feb; 15(2):131-6, 100. PubMed ID: 8645476
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary function monitoring during adenosine myocardial perfusion scintigraphy in patients with chronic obstructive pulmonary disease.
Johnston DL; Scanlon PD; Hodge DO; Glynn RB; Hung JC; Gibbons RJ
Mayo Clin Proc; 1999 Apr; 74(4):339-46. PubMed ID: 10221461
[TBL] [Abstract][Full Text] [Related]
6. Safety and clinical utility of combined intravenous dipyridamole/symptom-limited exercise stress test with thallium-201 imaging in patients with known or suspected coronary artery disease.
Ignaszewski AP; McCormick LX; Heslip PG; McEwan AJ; Humen DP
J Nucl Med; 1993 Dec; 34(12):2053-61. PubMed ID: 8254386
[TBL] [Abstract][Full Text] [Related]
7. Prediction of in-hospital cardiac events using dipyridamole-thallium scintigraphy performed very early after acute myocardial infarction.
Bosch X; Magriñá J; March R; Sanz G; García A; Betriu A; Navarro-López F
Clin Cardiol; 1996 Mar; 19(3):189-96. PubMed ID: 8674255
[TBL] [Abstract][Full Text] [Related]
8. Does dyspnoea during dipyridamole cardiac stress testing indicate bronchospasm and is the pretest clinical history predictive of this side-effect?
Leitha T; Gwechenberger M; Falger-Banyai S
Eur J Nucl Med; 1995 Dec; 22(12):1408-10. PubMed ID: 8586086
[TBL] [Abstract][Full Text] [Related]
9. Safety of intravenous dipyridamole for stress testing with thallium imaging.
Homma S; Gilliland Y; Guiney TE; Strauss HW; Boucher CA
Am J Cardiol; 1987 Jan; 59(1):152-4. PubMed ID: 3812227
[TBL] [Abstract][Full Text] [Related]
10. [Bronchospasm, apnea and heart arrest following dipyridamole perfusion scintigraphy].
Ottervanger JP; Haan D; Gans SJ; Hoorntje JC; Stricker BH
Ned Tijdschr Geneeskd; 1993 Jan; 137(3):142-3. PubMed ID: 8423863
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological stress myocardial perfusion scintigraphy: use of a modified adenosine protocol in patients with asthma.
Sundram F; Notghi A; Smith NB
Nucl Med Commun; 2009 Mar; 30(3):217-25. PubMed ID: 19262284
[TBL] [Abstract][Full Text] [Related]
12. Dipyridamole-thallium stress testing: a local community hospital experience.
Olatidoye AG; Baltazar RF
Md Med J; 1993 Jul; 42(7):663-7. PubMed ID: 8412526
[TBL] [Abstract][Full Text] [Related]
13. Dipyridamole thallium testing: noncardiac side effects, cardiac effects, electrocardiographic changes and hemodynamic changes after dipyridamole infusion with and without exercise.
Laarman GJ; Niemeyer MG; van der Wall EE; Verzijlbergen FJ; Go TL; Bruschke AV; Ascoop CA
Int J Cardiol; 1988 Aug; 20(2):231-8. PubMed ID: 3209253
[TBL] [Abstract][Full Text] [Related]
14. Safety of intravenous dipyridamole thallium myocardial perfusion imaging: experience in 435 patients.
Dubrey SW; Bomanji JB; Noble MI; Jewkes RF
Nucl Med Commun; 1993 Apr; 14(4):303-9. PubMed ID: 8479671
[TBL] [Abstract][Full Text] [Related]
15. Persistent myocardial ischemia after termination of dipyridamole-induced ventricular tachycardia by intravenous aminophylline: scintigraphic demonstration.
Chang WT; Lin LC; Yen RF; Huang PJ
J Formos Med Assoc; 2000 Mar; 99(3):264-6. PubMed ID: 10820963
[TBL] [Abstract][Full Text] [Related]
16. [Thallium-dipyridamole in acute myocardial infarction treated by thrombolysis: diagnostic and prognostic value].
D'Urbano M; Cafiero F; Cammelli F; Spreafico GL; Romano S
G Ital Cardiol; 1994 Jan; 24(1):11-20. PubMed ID: 8200491
[TBL] [Abstract][Full Text] [Related]
17. A comparison of dipyridamole-thallium imaging and exercise testing in the prediction of postoperative cardiac complications in patients requiring arterial reconstruction.
McPhail NV; Ruddy TD; Calvin JE; Davies RA; Barber GG
J Vasc Surg; 1989 Jul; 10(1):51-5; discussion 55-6. PubMed ID: 2746801
[TBL] [Abstract][Full Text] [Related]
18. Safety of dipyridamole-thallium imaging in high risk patients with known or suspected coronary artery disease.
Perper EJ; Segall GM
J Nucl Med; 1991 Nov; 32(11):2107-14. PubMed ID: 1941146
[TBL] [Abstract][Full Text] [Related]
19. Safety of pharmacological (intravenous dipyridamole) stress for Thallium-201 perfusion imaging in patients with coronary artery disease unable to exercise.
Zaman M; Hashmi R; Niaz K; Ahmad A; Kamal S
J Pak Med Assoc; 1994 Oct; 44(10):237-9. PubMed ID: 7815687
[TBL] [Abstract][Full Text] [Related]
20. Thallium-201 myocardial imaging during pharmacologic coronary vasodilation: comparison of oral and intravenous administration of dipyridamole.
Taillefer R; Lette J; Phaneuf DC; Léveillé J; Lemire F; Essiambre R
J Am Coll Cardiol; 1986 Jul; 8(1):76-83. PubMed ID: 3711534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
